geranylgeraniol has been researched along with Bisphosphonate Osteonecrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gjorgoski, I; Koneski, F; Krajoska, J; Muratovska, I; Petrushevska, G; Popovic-Monevska, D; Popovska, M; Popovski, V; Velickovski, B | 1 |
| Hagelauer, N; Pabst, AM; Walter, C; Ziebart, T | 1 |
| Blatt, S; Goetze, E; Jacobs, C; Krüger, M; Pabst, AM; Sagheb, K; Walter, C; Ziebart, T | 1 |
3 other study(ies) available for geranylgeraniol and Bisphosphonate Osteonecrosis
| Article | Year |
|---|---|
In vivo effects of geranylgeraniol on the development of bisphosphonate-related osteonecrosis of the jaws.
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Diterpenes; Imidazoles; Male; Rats; Rats, Wistar; Zoledronic Acid | 2018 |
Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cell Movement; Cell Survival; Cells, Cultured; Cyclohexenes; Diphosphonates; Diterpenes; Endothelial Cells; Eugenol; Farnesol; Fibroblasts; Humans; Imidazoles; Limonene; Menthol; Osteogenesis; Protein Prenylation; Recurrence; Squalene; Terpenes; Umbilical Veins; Zoledronic Acid | 2015 |
The influence of geranylgeraniol on microvessel sprouting after bisphosphonate substitution in an in vitro 3D-angiogenesis assay.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Diterpenes; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Microvessels; Neovascularization, Pathologic | 2017 |